Suppr超能文献

美国不断增加高 MELD 评分活体供肝肝移植的实践并获得可接受的结果。

Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.

机构信息

Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.

Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Liver Transpl. 2024 Jan 1;30(1):72-82. doi: 10.1097/LVT.0000000000000228. Epub 2023 Jul 26.

Abstract

Recent deceased-donor allocation changes in the United States may have increased high-Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); however, outcomes in these patients remain poorly defined. We aimed to examine the impact of the MELD score on LDLT outcomes. Using UNOS data (January 1, 2010-December 31, 2021), LDLT recipients were identified and stratified into low-MELD (<15), intermediate-MELD (15-24), and high-MELD (≥25) groups. We compared outcomes between MELD-stratified LDLT groups and between MELD-stratified LDLT and donation after brain death liver transplantation recipients. We used Kaplan-Meier analysis to compare graft survival rates and multivariable Cox proportional hazards modeling to identify factors associated with graft outcomes. Of 3558 LDLTs, 1605 (45.1%) were low-MELD, 1616 (45.4%) intermediate-MELD, and 337 (9.5%) high-MELD. Over the study period, the annual number of LDLTs increased from 282 to 569, and the proportion of high-MELD LDLTs increased from 3.9% to 7.7%. Graft survival was significantly higher in low-MELD versus high-MELD LDLT recipients (adjusted HR = 1.36, 95% CI: 1.03-1.79); however, 5-year survival exceeded 70.0% in both groups. We observed no significant difference in graft survival between high-MELD LDLT and high-MELD donation after brain death liver transplantation recipients (adjusted HR: 1.25, 95% CI:0.99-1.58), with a 5-year survival of 71.5% and 77.3%, respectively. Low LDLT center volume (<3 LDLTs/year) and recipient life support requirement were both associated with inferior graft outcomes among high-MELD LDLT recipients. While higher MELD scores confer graft failure risk in LDLT, high-MELD LDLT outcomes are acceptable with similar outcomes to MELD-stratified donation after brain death liver transplantation recipients. Future practice guidance should consider the expansion of LDLT recommendations to high-MELD recipients in centers with expertise to help reduce donor shortage.

摘要

最近美国的已故供者分配变化可能增加了高终末期肝病模型(MELD)评分的活体肝移植(LDLT);然而,这些患者的结局仍不清楚。我们旨在研究 MELD 评分对 LDLT 结局的影响。使用 UNOS 数据(2010 年 1 月 1 日-2021 年 12 月 31 日),确定 LDLT 受者并分为低 MELD(<15)、中 MELD(15-24)和高 MELD(≥25)组。我们比较了 MELD 分层 LDLT 组之间以及 MELD 分层 LDLT 组与脑死亡后肝移植受者之间的结局。我们使用 Kaplan-Meier 分析比较移植物存活率,并用多变量 Cox 比例风险模型确定与移植物结局相关的因素。在 3558 例 LDLT 中,1605 例(45.1%)为低 MELD,1616 例(45.4%)为中 MELD,337 例(9.5%)为高 MELD。在研究期间,LDLT 的年数量从 282 例增加到 569 例,高 MELD LDLT 的比例从 3.9%增加到 7.7%。低 MELD LDLT 受者的移植物存活率明显高于高 MELD LDLT 受者(调整 HR=1.36,95%CI:1.03-1.79);然而,两组的 5 年存活率均超过 70.0%。我们观察到高 MELD LDLT 受者与高 MELD 脑死亡后肝移植受者的移植物存活率之间没有显著差异(调整 HR:1.25,95%CI:0.99-1.58),5 年存活率分别为 71.5%和 77.3%。低 LDLT 中心容量(<3 例/LDLT 年)和受者生命支持需求均与高 MELD LDLT 受者的移植物不良结局相关。虽然较高的 MELD 评分会增加 LDLT 中的移植物失败风险,但高 MELD LDLT 的结局是可以接受的,与 MELD 分层脑死亡后肝移植受者的结局相似。未来的实践指南应考虑将 LDLT 建议扩大到有专业知识的中心的高 MELD 受者,以帮助减少供体短缺。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验